7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Sonnet BioTherapeutics Holdings, Inc
(NASDAQ:SONN) 

SONN stock logo

Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding (FHAB) technology, which utilizes human single chain antibodies fragment that binds to and hitch...

Founded: 1999
Full Time Employees: 30
CEO: Pankaj Mohan  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Sonnet BioTherapeutics Days Payable Outstanding ttm (DPO)
202101 202102 202103 202104 202105 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01,116.792,233.583,350.374,467.165,583.956,700.757,817.54
Sonnet BioTherapeutics Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0277.49554.98832.471,109.951,387.441,664.931,942.42
Sonnet BioTherapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -20.56-17.62-14.68-11.75-8.81-5.87-2.940
Sonnet BioTherapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -20.73-17.77-14.81-11.85-8.89-5.92-2.960
Sonnet BioTherapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.310.630.941.251.561.882.19
Sonnet BioTherapeutics P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0148.25296.5444.75593741.25889.511,037.76
Sonnet BioTherapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.07-5.21-4.34-3.47-2.6-1.74-0.870
Sonnet BioTherapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -119.18-96.42-73.66-50.9-28.14-5.3917.3740.13
No extra charts and metrics for this ticker.